Dissolution : PVT Mrs. Witinee Kongsuk Bureau of Drug and Narcotic November 27, 2015 Bureau of Drug and Narcotic
Dissolution : PVT
Mrs. Witinee Kongsuk Bureau of Drug and Narcotic
November 27, 2015 Bureau of Drug and Narcotic
Bureau of Drug and Narcotic 2
Background
Dissolution Assembly
Mechanical Calibration
Performance Verification Test
Factors Influence Dissolution Test
FAQ
Outline
Background
Tablets and capsules are the most commonly used
dosage forms.
Their efficacy and quality depended on
* Amount of active ingredient
* Dissolution rate, absorption to blood circulation
In vivo: volunteers, samples, time consuming,
routine quality control?
3 Bureau of Drug and Narcotic
Dissolution test
- Predict the bioavailability-surrogate parameter of the
therapeutic efficacy.
- Evaluate the rate of release of a drug substance from
the dosage form.
- Quality control tool to ensure the uniformity of product
among various batches / within one batch.
- Sensitive to variations in the manufacturing process
which have critical influence on the dosage form
performance.
4 Bureau of Drug and Narcotic
Apparatus 1 Basket • Vessel
- Glass or other inert transparent material
- Cylindrical with hemispherical bottom
- 1L, 2L or 4L nominal capacity
• Stirring shaft and basket
• Basket
- 40 mesh
- Gold coating of 2.5 um is allowed.
• Stirring
- rotating stirrer
- typical speeds: 50-100 rpm
• Dosage form placed in the basket
5 Bureau of Drug and Narcotic
Apparatus 2 Paddle
• Vessel
- same as for Apparatus 1
• Stirring blade and shaft
- metallic or suitably inert and rigid
- may be coated
• Agitation
- rotating stirrer
- typical speeds: 50-75 rpm
• Dosage form should remain
at the bottom center of the vessel
6 Bureau of Drug and Narcotic
Visual Inspection
o Check for leaks: tubing, joints
o Circulation pump: check for leaks, trapped air, noise
o Good practice to regularly change water
o Use clean and clear water
o Keep bath clean o Ensure adequate water level
Water bath
8 Bureau of Drug and Narcotic
Visual Inspection
Vessel
o Thorough cleaning is very important.
o Sticky residues can build up on glass surface.
o Always check the internal surface
o Irregular curvature can affect hydrodynamics.
o Check periodically during use looking for cracks,
scratches and build up of deposit or residue.
10 Bureau of Drug and Narcotic
Visual Inspection
o It is very important to carefully observe
the physical condition.
o Shaft for both apparatus must be straight.
o Loose basket clips will cause wobble.
o Basket should be right cylinders (not bent).
o Baskets that are old, distorted or frayed can give
non-reproducible results.
o Baskets should be properly cleaned and stored.
o Ensure vent hole in basket head is clear.
o Baskets should be attached carefully to the shaft.
o Paddles: smooth coating, if coated
Baskets and Paddles
14 Bureau of Drug and Narcotic
The USP defines the sampling position as “A zone midway between the surface of the dissolution
medium and the top of the rotating basket or blade, not
less than 1 cm from the vessel wall"
Canular
Dissolution Assembly
15 Bureau of Drug and Narcotic
History: USP Dissolution test USP XVIII
(1970)
Dissolution test became official in USP
USP XX
(1980)
Apparatus Suitability Test
USP 30
(2007)
Apparatus Suitability:
Performance Verification Test (PVT)
USP 32
(Dec 1, 2009)
- The PVT using Salicylic acid tablets RS
is no longer required for USP App 1 and 2
- USP move from acceptance criteria for
individual tablet results to a new set of
acceptance criteria using the GM and %CV
obtained from the dissolution results
USP 34 to ..
(2011)
Prednisone Tablets RS for App 1 and 2
17
The new testing procedure and the acceptance criteria will be provided
in the Technical Data Sheet accompanying the new lot of the reference material.
Bureau of Drug and Narcotic
Collaboration with USP
Training:
• 24 June, 2010
Ms. Barbara B. Hubert
Mr. Paul J. Crown
• 27-28 Aug, 2015
Mr. Paul J. Crown
Mr. Joseph Eaton
Collaborative study to establish
acceptance range for the next lot
USP Prednisone Tablets for
dissolution App 1 and App 2:
Since June, 2009 18
Bureau of Drug and Narcotic
Calibration
• Evaluation of dimensional and functional conformance to specification
Mechanical Calibration
• Confirmation the acceptable operation of the equipment
Performance Verification Test
(PVT)
19 Bureau of Drug and Narcotic
References: - USP 38: <711> Dissolution
- USP Prednisone Tablets RS Certificate
- Dissolution Toolkit Version 2.0
o Conformance to USP specification
o Position designation in the assembly
- Stirring elements
* Shafts
* Blade or baskets
- Vessels
o Recommendation:
Maintain the same position for vessels / stirring
elements within the assembly throughout a PVT cycle
Mechanical Calibration
20 Bureau of Drug and Narcotic
Mechanical Calibration
Shaft verticality
o Deviations of greater than 1.5º
can result in change in
dissolution results
o Can be checked using
a digital protractor
o Check at two planes perpendicular
to each other o Recommendation: <0.5º
22 Bureau of Drug and Narcotic
Mechanical Calibration Shaft centering
o The shaft is positioned so that its axis is < 2 mm
at any point from the vertical axis of the vessel o Use a centering gauge
24 Bureau of Drug and Narcotic
Mechanical Calibration
Wobble
- Rotates smoothly
without significant wobble
that could affect the results - Recommendation: + 0.5 mm
25 Bureau of Drug and Narcotic
Mechanical Calibration
Rotation speed
o Usually checked with a tachometer
(rotation speed gauge)
- or check manually using a timer
o Measure each spindle for until
a stable reading is obtained
- USP specification: + 4%
o Recommendation:
all measured speeds should be within + 1 rpm of the set value.
26 Bureau of Drug and Narcotic
Mechanical Calibration
Temperature control
Calibrated thermometer
37 + 0.5 ˚C
Distance between the inside bottom of the vessel
and the bottom of the basket or paddle is maintained
at 25 + 2 mm during the test use a spacing gauge or ball
27 Bureau of Drug and Narcotic
USP Performance Verification Test (PVT)
• Provide experimental proof that the dissolution test
assembly is suitable for dissolution testing
• Confirms the acceptable operation of the equipment
• The result must conform to range given in the
certificate for the specification lot of reference material.
• PVT is a prerequisite for a proper performance
qualification of the dissolution assembly.
28 Bureau of Drug and Narcotic
Reference Standards for PVT
Always use the current lot
Follow the instructions on the label concerning storage and handling
29 Bureau of Drug and Narcotic
Prednisone USP RS
Check
• Current lot • Validity
Current Lot: O0G356
Previous Lot: N0E330 (Valid Use Date: 31-May-2009) 30 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Check
• Current lot • Validity
Current Lot: R031Y0 (Valid Use Date: 30-Sep-2016)
Previous Lot: R001B1 (Valid Use Date: 31-Dec-2015)
32 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Do not push tablets through foil backing.
To remove tablets from blister, peel foil.
Use only whole tablets.
Store in a dry place.
Store at controlled room temperature
Not exceeding 25 ºC
Unused or unopened blister strips should be kept in the secondary package.
Certificate & Label
34 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Information:
- Calculation value
- Expiration
- Instruction of use
- Legal notice
Certificate & Label
Expiration!!!
It is the responsibility of each user to determine that
this lot is current or valid when used.
35 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
- Store in a dry place.
- Store the tablets at controlled room temperature
not exceeding 25º
36 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Dissolution medium:
- Steps to prepare the medium “deaerated water”
37 Bureau of Drug and Narcotic
USP Deaeration Technique
Note: - Vacuum should be less than 100 mbar - Temperature of medium should not fall below 37°C
Heat water while stirring gently
to about 41 – 45 C
Filter under vacuum through 0.45 um porosity filter
(HVLP type or equivalent) into a filtering flask with a stirring device
Seal the flask,
continue to apply vacuum
while stirring for an additional 5 min
38 Bureau of Drug and Narcotic
Procedure
alcohol < 5% of total volume of standard solution (If used)
Deaeration step
Weight and carefully introduce dissolution medium
to the vessel 499 g (correspond to 500 ml)
Allow media in each vessel to reach
37 + 0.5 ºC and use immediately
Perform dissolution test : single or two stage (each apparatus at 50-rpm)
Determine the quantity of prednisone dissolved
at 30 minutes in each vessel (uv at 242 nm)
39 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Result:
• GM • %CV
App # of vessels
Single-Stage
Two-Stage
1st Stage of Two Stages
2nd Stage of Two Stages
GM* %CV GM* %CV GM* %CV
1
6
51-80
11
55-74
8.2
51-80
11 7
8
12 na
14 na
2
6
27-41
6.4 29-38
4.7 27-41
6.3 7 6.3
8 6.2 4.8 6.2
12 6.3 na
14 6.2 na
*Percent of the labeled amount of prednisone dissolved at 30 minutes at 50-rpm
Lot R031Y0
40
Bureau of Drug and Narcotic
“passed the PVT”
41 Bureau of Drug and Narcotic
USP Prednisone Tablets RS
Criteria for PVT
• must not fall outside the limit GM
• must not be greater than the limit %CV
meet the criteria
meet the criteria
USP Prednisone Tablets RS
Futility Factor
%CV at or above value given,
second stage testing will not produce passing result
42 Bureau of Drug and Narcotic
www.usp.org
Search for
PVT calculation tool
Select “Begin using the tool”
PVT Calculation Toolkit
43 Bureau of Drug and Narcotic
Recommendations for PVT
- Designated vessels and shaft for each position
in dissolution instrument
- Rigorous mechanical calibration
- Proper deaeration of dissolution medium
- Test should be started as soon as possible
after media deaeration
- Always handle tablets with
* gloves (not cotton)
* forceps or tweezers which will not scratch or
damage the surface of the tablets
54 Bureau of Drug and Narcotic
• Do not use chipped, cracked or capped tablets
• For Apparatus 2 Paddle
- Drop tablets into non-rotating apparatus
- Tablets must settle to the bottom of the vessel
before rotation of the shaft begins.
• Samples should remain at the bottom center
of the vessel
• Visually inspect and record any unusual observations
• Filter samples immediately after withdrawing
samples from each vessel
55 Bureau of Drug and Narcotic
Recommendations for PVT
USP Prednisone Tablets RS
Tablet should be stored in original container,
according to description on label
Remove tablets from package immediately
prior to testing
Do not put tablet RS next to water bath
while waiting for bath to equilibrate
Avoid exposure to excess humidity
Prednisone Tablets RS will give low results
Do not dry Prednisone Tablets RS in an oven
No need to weigh Tablets RS beforehand (Weight is for information and investigation purposes)
56
Bureau of Drug and Narcotic
Sources of factors influence dissolution
Note: instrument and analyst are qualified 57
Bureau of Drug and Narcotic
Laboratory environment
Medium
Filtration
Quantitative method
USP specification:
“ No part of the assembly, including the environment
in which the assembly is placed, contributes significant
motion, agitation, or vibration beyond that due to the
smoothly rotating stirring element.”
Source of vibration:
* Apparatus
- Tension or dirt on the drive chain or belt
- Worn parts
- Alignment of belt guide plates
- Surging of individual spindles
- Turbulence in the water bath
58 Bureau of Drug and Narcotic
Laboratory Environment: Vibration
Laboratory Environment
Has anything changed in the lab environment?
- New equipment added to the immediate area
- Other changes (e.g. construction)
Vibration transfer
- Be careful how many testers put on the same bench
- Is bench suitable?
- What else is on the bench or nearby?
shaker, mixer, centrifuge
- consider use of vibration damping pads
59 Bureau of Drug and Narcotic
Medium
Using deaerated media
- use immediately after deaeration
- transfer media carefully to minimize re-aeration
of the media
Air bubbles can attach to particles
- decreasing dissolution by reducing surface area
- Increasing dissolution by
# lifting and moving particles
# bubble clogging the meshes of the basket
and retaining particles in a zone of higher
shear stress compare to the vessel bottom
60 Bureau of Drug and Narcotic
Filtration
Removal of undissolved particles
i.e. drug or excipients in the sample solution
Filtration should occur concomitantly with or
immediately after sampling.
Unfiltered sample can continue drug dissolution
before filtration.
Use Individual, clean syringes and filters
for sampling each vessel, each time.
61 Bureau of Drug and Narcotic
Filtration Precautions:
- Prewetting may be necessary.
- Adsorption of the drug onto the filter has to be
evaluated.
- Chemical compatibility and extractable impurities
should be considered by the selection of
the proper (inert) filter material.
- Important to perform filter check / validation.
*** PVDF membrane filter is recommended for PVT.
62 Bureau of Drug and Narcotic
Quantitative Method Standard Preparation
- Prednisone USP RS
- Alcohol < 5% of total volume of Standard solution
(If used)
- Prepared Working and Control Standard
- Calculated absorptivity (AU per mg/ml) values of
working and control standards should be
in agreement with historic values and
within 1% of each other.
UV Spectrophotometry
- Calibrated UV-Vis spectrophotometer
- λmax at 242 nm
- 1.0 cm path-length quartz cell 63
Bureau of Drug and Narcotic
When to perform PVT ?
Installation of new apparatus
Movement or relocation of apparatus
Equipment maintenance
- Adjustment of drive mechanism
- Replacement of drive belt
- Replacement of circulator
- Replacement of vessels, baskets, paddle etc
Routine test schedule
If only one apparatus, basket or paddle, is used,
then only that apparatus needs to be tested.
64 Bureau of Drug and Narcotic
65 Bureau of Drug and Narcotic
FAQ
Q: How many runs have to be performed for the PVT?
A: Current approach for PVT
Single stage: Performance of two consecutive runs
including all positions of dissolution instrument.
The combined results for both runs will be evaluated
and compared with the acceptance criteria.
Two-stage: allow the analyst to evaluate the results
of the 1st run and compare it with the acceptance criteria
If the results are within the 1st stage acceptance criteria,
the PVT test can be stopped at this stage.
For 12 or 14 positioned assembly: a single run is required
66 Bureau of Drug and Narcotic
FAQ
Q: Did the method to perform the PVT using the current
lot change from the previous lot?
A: The method to perform the PVT has not changed from
the previous lot. USP provided some recommendations
to help customers achieve a successful PVT in the
Dissolution Toolkit. The procedure for the PVT is given in
the USP Certificate.
67 Bureau of Drug and Narcotic
FAQ
Q: What is the storage condition for
USP Prednisone Tablets RS catalog#1559505?
A: USP Prednisone Tablets RS should be stored as per
the label. Please refer to General Chapter <659> for
storage and handling definitions.
68 Bureau of Drug and Narcotic
FAQ
Q: When does a particular lot of USP Prednisone
Tablets RS catalog # 1559505 expired?
A: Unlike other USP Reference Standards, a period of validity
is proven on the USP Certificate of USP Prednisone
Tablets RS. This date is final and will not be extended.
A specific lot should not be used after its assigned valid
use date.
69 Bureau of Drug and Narcotic
FAQ
Q: What should I do if the PVT for Apparatus 1 passes
and then fails for Apparatus 2?
A: If nothing but stirring elements are changed when
switching from Apparatus 1 to Apparatus 2, then the PVT
for Apparatus 1 is considered to be successful.
The cause of failure should be investigated and
any adjustments made.
If the cause is paddle stirring elements and
no other changes are made, the PVT has to be repeated
for Apparatus 2 only.
If any changes are made other than the replacement
of the paddle stirring elements, the PVT should be
repeated for both Apparatus 1 and 2.